OTCPK:WLDCF - Post by User
Post by
purseon Feb 13, 2018 10:46pm
349 Views
Post# 27555168
Just a mater of time - Read last sentence
Just a mater of time - Read last sentence
The Globe and Mail reports in its Tuesday edition that Canaccord analyst Neil Maruoka says Canopy Growth ($26.90) is "well-positioned to be a dominant global player." The Globe's David Leeder writes in the Eye On Equities column that Mr. Maruoka continues to rate the shares "hold." He elevated his share target to $26 from $18.50. Analysts on average target the shares at $29.94. Mr. Maruoka says in a note: "Never before have we witnessed burgeoning international markets with essentially no competition from U.S. industry (given currently restrictive federal legislation). As other countries seek to establish durable and stable cannabis infrastructure, we believe that Canadian companies are poised to take a leadership role through the export of both product and production know-how. We believe the most near-term and significant opportunity for Canadian LPs is the German medical market. However, other European markets are also emerging, and are increasingly attractive given high reimbursement and medical pricing. We believe this is important given the potential oversupply and commoditization of cannabis in Canada. Other near- and medium-term potential opportunities for Canopy include South America and Australia."